Nephros Q1 2024 GAAP EPS $(0.02) Beats $(0.04) Estimate, Sales $3.522M Miss $3.734M Estimate
Nephros Q1 2024 GAAP EPS $(0.02) Beats $(0.04) Estimate, Sales $3.522M Miss $3.734M Estimate
Nephros 2024 年第一季度公認會計准則每股收益 (0.02) 超過預期 (0.04) 美元，銷售額352.2萬美元，低於373.4萬美元的預期
Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.04) by 50 percent. This is a 33.33 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $3.522 million which missed the analyst consensus estimate of $3.734 million by 5.68 percent. This is a 4.73 percent decrease over sales of $3.697 million the same period last year.
Nephros（納斯達克股票代碼：NEPH）公佈的季度虧損爲每股0.02美元，比分析師普遍預期的0.04美元（0.04美元）高出50％。與去年同期每股虧損0.03美元（0.03）相比，增長了33.33％。該公司公佈的季度銷售額爲352.2萬美元，比分析師普遍預期的373.4萬美元低5.68％。這比去年同期的369.7萬美元的銷售額下降了4.73％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。